Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel PTP1B inhibitors prepared and tested by JT researchers

July 14, 2003

FDA advisory committee hands down positive opinion for Crestor

July 11, 2003

Repaglinide vs. nateglinide in combination with metformin for type 2 diabetes

July 11, 2003

FDA requests additional data for Follistim

July 11, 2003

Novocell encapsulated islet cell implants successful in diabetic primates

July 11, 2003

PT-100 and Rituxan combination trial under way

July 10, 2003

EMEA approves Pfizer's Genotropin

July 10, 2003

Exemestane beneficial in cirrhotic patients with hypogonadism

July 10, 2003

Angeliq cleared for pan-European launch

July 9, 2003

Puricase advances through the clinical pipeline for refractory gout

July 9, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...